Songwei Tan
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 27
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems 5
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics 23
- Graphene and Nanomaterials Applications 7
- Molecular Medicine top 2%
- Immunology top 5%
- Immunotherapy and Immune Responses 10
-
- RNA Interference and Gene Delivery 20
-
- Virus-based gene therapy research 7
-
- Drug Transport and Resistance Mechanisms 5
- Co-authors
- Zhiping ZhangYuanyuan GuoTingting WuSi‐Shen FengYuling BaoDan ZhangXiangting ZhuangJun Luo
- Journals
- Advanced Materials (1 paper)SHILAP Revista de lepidopterología (1 paper)Nano Letters (1 paper)
- Partner nations
- ChinaUnited StatesIran
In The Last Decade
Songwei Tan
70 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Biomaterials 1.9k
- Pharmaceutical Science 552
- Biomedical Engineering 1.8k
- Molecular Medicine 171
- Immunology 718
Countries citing papers authored by Songwei Tan
This map shows the geographic impact of Songwei Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Songwei Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Songwei Tan more than expected).
Fields of papers citing papers by Songwei Tan
This network shows the impact of papers produced by Songwei Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Songwei Tan. The network helps show where Songwei Tan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Songwei Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 6 | |
| 6 | 2024 | 16 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 19 | |
| 9 | 2022 | 32 | |
| 10 | 2020 | 33 | |
| 11 | 2020 | 38 | |
| 12 | 2020 | 23 | |
| 13 | 2019 | 47 | |
| 14 | 2018 | 44 | |
| 15 | 2017 | 160 | |
| 16 | 2016 | 26 | |
| 17 | 2016 | 129 | |
| 18 | Cell or Cell Membrane-Based Drug Delivery Systemsbreakdown → | 2015 | 410 |
| 19 | 2015 | 26 | |
| 20 | 2012 | 114 |
About Songwei Tan
Songwei Tan is a scholar working on Biomaterials, Pharmaceutical Science and Immunology, having authored 72 papers that have together received 4.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (27 papers), Nanoplatforms for cancer theranostics (23 papers), RNA Interference and Gene Delivery (20 papers), Immunotherapy and Immune Responses (10 papers), Virus-based gene therapy research (7 papers), Graphene and Nanomaterials Applications (7 papers), Advanced Drug Delivery Systems (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). The work is most often cited by research in Biomaterials (1.9k citations), Pharmaceutical Science (552 citations) and Biomedical Engineering (1.8k citations). Songwei Tan has collaborated with scholars based in China, United States and Iran. Frequent co-authors include Zhiping Zhang, Zhiping Zhang, Yuanyuan Guo, Tingting Wu, Si‐Shen Feng, Yuling Bao, Dan Zhang, Xiangting Zhuang, Jun Luo and Qingle Song. Their work appears in journals such as Advanced Materials, SHILAP Revista de lepidopterología and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.